Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Dare Bioscience, Inc. (DARE)

Daré Bioscience furnishes corporate presentation dated September 9, 2026

Neutral Impact 1 of 5 other Written later

Daré Bioscience filed a Form 8-K furnishing a corporate presentation dated September 9, 2026, as Exhibit 99.1, for use in meetings with securities market participants starting that day. The filing is administrative and contains no financial results, guidance, or deal terms in the text provided, and the presentation content was not included in the filing text.

Key points

  • Corporate presentation dated September 9, 2026 furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure)
  • Company plans to use the presentation in investor meetings commencing September 9, 2026
  • Presentation to be posted on the Investors section of the company website, ir.darebioscience.com

The filing

CompanyDare Bioscience, Inc. (DARE)
Form8-K, current report
Filed with the SECSep 9, 2026, 9:00 AM ET
Accession number0001493152-26-041904

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.